Anti-γ-Aminobutyric Acid Type β Receptor Antibody-Associated Encephalitis After 2 Cycles of Durvalumab Therapy in a Patient with Small Cell Lung Cancer: A Case Report

Código QR

Anti-γ-Aminobutyric Acid Type β Receptor Antibody-Associated Encephalitis After 2 Cycles of Durvalumab Therapy in a Patient with Small Cell Lung Cancer: A Case Report

Jiamo Li,1 Jianing Jiang,1,2 Jinyan Lv,1 Ru Zhang,1 Wenting Chen,1,2 Shiyi Li,1 Qianchen Jin,1 Gang Wang1,2 1Department of Medical Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Province, People’s Republic of China; 2The Key Laboratory of Biomarker, High-Throughpu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Li J, Jiang J, Lv J, Zhang R, Chen W, Li S, Jin Q, Wang G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	anti-gababr antibody autoimmune encephalitis immunotherapies small cell lung cancer durvalumab Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/715ea3d186ce4717aa84511ac7a29517
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
por: Fitzpatrick O, et al.
Publicado: (2021)

Autoimmune encephalitis with coexistent LGI1 and GABABR1 antibodies: case report
por: Yi Xie, et al.
Publicado: (2021)

Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer
por: Galina B. Statsenko, et al.
Publicado: (2020)

Coexistence of Anti-SOX1 and Anti-GABAB Receptor Antibodies with Autoimmune Encephalitis in Small Cell Lung Cancer: A Case Report
por: Qin W, et al.
Publicado: (2020)

Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report
por: Albina S. Zhabina, et al.
Publicado: (2021)

Autoimmune basal ganglia encephalitis associated with anti-recoverin antibodies: A case report
por: Yuki Kitazaki, et al.
Publicado: (2021)

A Retrospective Study of Patients with GABABR Encephalitis: Therapy, Disease Activity and Prognostic Factors
por: Wen X, et al.
Publicado: (2021)

The role of dendritic cells and their interactions in the pathogenesis of antibody-associated autoimmune encephalitis
por: Fatme Seval Ismail, et al.
Publicado: (2021)

Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience
por: Vrankar Martina, et al.
Publicado: (2021)

Comparisons Between Infectious and Autoimmune Encephalitis: Clinical Signs, Biochemistry, Blood Counts, and Imaging Findings
por: Huang CN, et al.
Publicado: (2020)

EEG Contribution to the Diagnosis of Antibody-Negative Autoimmune Encephalitis: A Case Report
por: Mayusa Mito, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives
por: Inoue H, et al.
Publicado: (2020)

Chimeric Antibody 14D5 Protects Mice against the Far-Eastern, Siberian, and European Tick-borne Encephalitis Virus
por: Andrey L. Matveev, et al.
Publicado: (2019)

Case Report: Prominent Brainstem Involvement in Two Patients With Anti-CASPR2 Antibody-Associated Autoimmune Encephalitis
por: Pei Liu, et al.
Publicado: (2021)

Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus
por: Estefania Fernandez, et al.
Publicado: (2018)

Clinical features of limbic encephalitis with LGI1 antibody
por: Wang ML, et al.
Publicado: (2017)

Encefalitis autoinmune por anticuerpos contra el receptor GABA-A: Caso clínico
por: González R,Pablo, et al.
Publicado: (2016)

Novel Immunotherapeutic Approach in Gastric Cancer
por: Gulubova M., et al.
Publicado: (2020)

Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study
por: Qiao S, et al.
Publicado: (2021)

Comprehensive assessment of specific antibodies on infectious activity of tick-borne encephalitis virus
por: G. N. Leonova, et al.
Publicado: (2019)

Gamma Interferon Alters Junctional Integrity via Rho Kinase, Resulting in Blood-Brain Barrier Leakage in Experimental Viral Encephalitis
por: Stephanie Bonney, et al.
Publicado: (2019)

Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review
por: Wang HY, et al.
Publicado: (2019)

Neoadjuvant immunotherapy combined with chemotherapy for locally advanced squamous cell lung carcinoma: A case report and literature review
por: Zheng Yuan, et al.
Publicado: (2021)

An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
por: Tomoyoshi Komiya, et al.
Publicado: (2021)

The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
por: Xin Xie, et al.
Publicado: (2022)

Risk Factors and Brain Metabolic Mechanism of Sleep Disorders in Autoimmune Encephalitis
por: Xiao Liu, et al.
Publicado: (2021)

Failure to improve after ovarian resection could be a marker of recurrent ovarian teratoma in anti-NMDAR encephalitis: a case report
por: Uchida Y, et al.
Publicado: (2018)

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Hyeree Choi, et al.
Publicado: (2021)

ANTIBODIES TO BENZO[A]PYRENE IN SERUM OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
por: E. G. Polenok, et al.
Publicado: (2012)

Encefalitis autoinmunes: criterios diagnósticos y pautas terapéuticas
por: Collao-Parra,Juan Pablo, et al.
Publicado: (2018)

Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection <italic toggle="yes">In</italic> <italic toggle="yes">Vitro</italic> and in a Mouse Model
por: James Duehr, et al.
Publicado: (2018)

Immunotherapeutic Advances for NSCLC
por: Massafra M, et al.
Publicado: (2021)

The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy
por: Hamilton G, et al.
Publicado: (2021)

Monoclonal antibodies in immunodiagnosis and immunotherapy

Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Damian Mojsak, et al.
Publicado: (2021)

Predictive Value of GAD Antibody for Diabetes in Normal Chinese Adults: A Retrospective Cohort Study in China
por: Li J, et al.
Publicado: (2021)

Assessing natural herd immunity to tick-borne encephalitis in Republic Sakha (Yakutia)
por: A. G. Dragomeretskaya, et al.
Publicado: (2019)

A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
por: Alessio Bruni, et al.
Publicado: (2021)

RESULTS OF GENOTYPING OF STRAINS AND RNA ISOLATES OF TICK-BORNE ENCEPHALITIS VIRUS ISOLATED FROM SICK PEOPLE IN IRKUTSK REGION AND BURYAT REPUBLIC
por: I. V. Kozlova, et al.
Publicado: (2012)

Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
por: Alessio Bruni, et al.
Publicado: (2021)